![]() |
市場調查報告書
商品編碼
1792420
2025 年至 2033 年人工心肺機市場報告(按類型、應用、最終用戶和地區)Artificial Heart-Lung Machine Market Report by Type, Application, End User, and Region 2025-2033 |
2024年全球人工心肺機市場規模達3.026億美元。展望未來, IMARC Group預計到2033年市場規模將達到4.016億美元,2025-2033年期間的成長率(CAGR)為3.04%。
人工心肺機,又稱為心肺旁路 (CPB) 或氧合泵,用於冠狀動脈繞道手術、心肺移植以及其他心臟手術。它暫時執行心臟和肺部的功能,使外科醫生能夠在運動和無血的手術環境中進行手術。這些機器由一個腔室組成,用於接收血液,然後將血液氧合併循環到身體的各個部位。多年來,這些幫浦在嚴重呼吸衰竭的治療以及心臟外科手術領域取得了顯著進展。
近年來,全球開胸手術、心臟移植和肺部手術的數量顯著增加。這主要歸因於各種環境和生活方式的變化,這些變化導致心血管疾病和器官衰竭的發生率上升。此外,一些發展中國家的政府正在努力為患者提供更好的醫療設施,這推動了對人工心肺機的需求。此外,市場參與者正在投資研發活動,以更新現有的氧合泵型號。這些活動促成了模組化心肺機的開發,這種機器具有成本效益、安全性和方便用戶使用性。此外,這些機器還為醫生提供了靈活性,因為它們便於攜帶,並且可以使用充電電池供電。製造商也對體外循環幫浦進行了多項改進,以防止血液過度氧合。
The global artificial heart-lung machine market size reached USD 302.6 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 401.6 Million by 2033, exhibiting a growth rate (CAGR) of 3.04% during 2025-2033.
An artificial heart-lung machine, also known as a cardiopulmonary bypass (CPB) or oxygenator pump, is used during coronary artery bypass, heart and lung transplants, and other cardiac surgeries. It temporarily performs the functions of the heart and lungs to enable the surgeon to operate in motion and bloodless surgical field. These machines consist of a chamber that receives blood, which is then oxygenated and circulated to all body parts. Over the years, these pumps have helped in making significant advances in the management of severe respiratory failure as well as in the field of car-diac surgeries.
In recent years, there has been a significant rise in the number of open-heart surgeries, heart transplants and lung surgeries across the globe. This can primarily be attributed to various environmental and lifestyle changes, which have led to an increase in the prevalence of cardiovascular diseases and the instances of organ failures. Other than this, governments of several developing nations are making efforts for providing improved healthcare facilities to patients, which is driving the demand for artificial heart-lung machines. Furthermore, the market players are investing in research and development activities to modernize the current models of oxygenator pumps. These activities have led to the development of modular heart-lung machines that are cost-effective, safe, and user-friendly in nature. Besides this, these machines also offer flexibility to doctors as they are portable and can be operated on rechargeable batteries. The manufacturers have also made several improvements in CPB pumps to prevent the over-oxygenation of blood.
The report has also analysed the competitive landscape of the market with some of the key players being Medtronic Inc., Sorin Group, MAQUET GmbH & Co KG, Terumo Corporation, C.R. Bard Inc., Tianjin Welcome Medical Equipment Co., Ltd., Edwards Lifesciences, Jarvik Heart Inc., Braile Biomedica, SynCardia Systems, LLC, etc.